Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endometrial carcinoma in tamoxifen-treated breast cancer patient: clinicopathological, immunohistochemical, and genetic analysis.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Oct 1999

Esteller M, Garcia A, Martinez-Palones J M, Xercavins J, Reventos J

Abstract excerpt

Endometrial polyps and endometrial neoplasms are a recognized complication of chronic tamoxifen treatment. This study describes an endometrial carcinoma that developed in a woman receiving low-dose tamoxifen treatment for breast cancer. Little is known about steroid receptor status, somatic alterations in oncogenes and tumor suppressor genes, and inherited susceptibility in endometrial carcinomas associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Neoplasms, Second Primary

Share to Oxidoreductases Acting on CH-NH Group Donors

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Tamoxifen

Source

Identifiers

PMID: 10542949
DOI: 10.1097/00004347-199910000-00015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endometrial carcinoma in tamoxifen-treated breast cancer patient: clinicopathological, immunohistochemical, and genetic analysis.PMID 10542949Read ↗

Molecular genetic characterization of tamoxifen-associated endometrial cancer.Semantic proximity Read ↗

Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.Semantic proximity Read ↗

Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use.Semantic proximity Read ↗

A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer.Semantic proximity Read ↗

Risk of endometrial carcinoma associated with BRCA mutation.Semantic proximity Read ↗

Molecular analysis in endometrial cancer.Semantic proximity Read ↗

The role of estrogen receptor mutations in tamoxifen-stimulated breast cancer.Semantic proximity Read ↗

Mutational analysis of the BRCA1 tumor suppressor gene in endometrial carcinoma.Semantic proximity Read ↗

Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.Semantic proximity Read ↗

An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptor.Semantic proximity Read ↗

K-ras mutation in tamoxifen-related endometrial polyps.Semantic proximity Read ↗

Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibilitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.